Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GLUL | P15104 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | GRM8 | O00222 | 1/20 | 0.32 |
| ▸ | GRM6 | O15303 | 1/20 | 0.32 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1804921 | 0.83 | CA4 (0.42) | CA4GLULPEPDPGD | |
| SCHEMBL9802024 | 0.83 | CA4 (0.42) | CA4GLULPEPDPGD | |
| SCHEMBL27898509 | 0.82 | CA4 (0.38) | CA4GLULCYP2D6CYP2C9CYP2C19 | |
| Magnesium SCHEMBL9801770 | 0.81 | CA4 (0.41) | CA4PEPDPGD | |
| Calcium SCHEMBL9802006 | 0.81 | CA4 (0.41) | CA4PEPDPGD | |
| SCHEMBL641432 | 0.80 | GRM3 (0.52) | CYP2D6GRM8GRM6GRM7GRM4 | |
| SCHEMBL3659563 | 0.80 | CA4 (0.37) | CA4GLULCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL8919007 | 0.80 | GSR (0.44) | CA4 | |
| SCHEMBL641431 | 0.80 | GRM3 (0.52) | CYP2D6GRM8GRM6GRM7GRM4 | |
| SCHEMBL2351136 | 0.80 | ALOX15 (0.50) | CA4GLULCYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110267655-A | The treatment method of amino acid composition and muscle disease and illness | 胺细拉健康公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-104685058-A | Microorganisms and methods for making 4-hydroxybutyrate, 1, 4-butanediol, and related compounds | GENOMATICA INC | 2015-06-03 | — | — | CN | disclosed |